CellNetix Pathology & Laboratories, one of the largest independent pathology service providers in the United States, is innovating its practice with digital pathology to advance its mission of excellence via a new partnership with digital and computational pathology solutions provider Proscia.
Accelerated by a growing base of evidence, laboratories are adopting digital pathology to optimise routine operations, increase the confidence of decision making, enhance the pathologist experience, and unlock new insights with AI. CellNetix is working with Proscia, a leading provider, to complete its transformation and digitise a portion of its 1 million glass slides per year.
“At CellNetix, we are mission-driven and pride ourselves on quality and delivering more precise results,” said Kathleen Fondren, CEO of CellNetix. “Adopting digital pathology is critical to furthering this aim. Proscia has established itself as a leading player in the space, and we are confident that working with the team will enable us to quickly realise the unprecedented potential of this innovation.”
In modernising its practice with Proscia, CellNetix will achieve greater flexibility along with productivity and efficiency gains in its routine workflows. It will also streamline collaboration among the 60+ pathologists distributed across its regional network, broadening access to expertise. The new technology will also pave the way to unlock new insights with AI and capitalise on the wealth of real-world data that it generates.
“CellNetix is ideally positioned to benefit from AI-powered digital pathology at scale,” said David West, Proscia’s CEO. “Its commitment to excellence is backed by a strong culture of innovation and collaboration. We look forward to seeing the impact of our efforts together, both immediately and as the promise of the technology continues to grow.”